Detecting New Synthetic Drugs

Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.

Written byCristina Luiggi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

DREAMSTIME, HENRISCHMIT

Underequipped and inadequately staffed forensic laboratories around the United States are likely to miss the new class of synthetic drugs that are cropping up, mostly in China, said chemists at the American Chemical Society meeting in Denver, Colorado. The drugs, which are synthesized to mimic existing illegal substances while evading detection, represent a growing problem worldwide. Detecting them requires laboratories to have a pure sample for comparison using analytical techniques such as gas-column mass spectrometry (GCMS), but such samples are hard to come by. Another problem is that many forensic labs may be staffed by people without the proper training in analytical chemistry.

"If you're doing GCMS on a sample and it almost matches mephedrone, well maybe it's butylone [a psychedelic drug used in research]," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies